Tango Therapeutics, Inc. (TNGX)
21.84
-0.06
(-0.25%)
USD |
NASDAQ |
Oct 07, 16:00
21.84
0.00 (0.00%)
After-Hours: 19:41
Tango Therapeutics EPS Diluted (Quarterly) : -0.3692 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3692 |
| March 31, 2026 | -0.317 |
| December 31, 2025 | -0.2945 |
| September 30, 2025 | 0.1431 |
| June 30, 2025 | -0.3515 |
| March 31, 2025 | -0.3615 |
| December 31, 2024 | -0.3466 |
| September 30, 2024 | -0.2688 |
| June 30, 2024 | -0.2359 |
| March 31, 2024 | -0.3505 |
| December 31, 2023 | -0.3164 |
| September 30, 2023 | -0.2294 |
| June 30, 2023 | -0.2344 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.3176 |
| December 31, 2022 | -0.3303 |
| September 30, 2022 | -0.3305 |
| June 30, 2022 | -0.283 |
| March 31, 2022 | -0.2875 |
| December 31, 2021 | -0.2518 |
| September 30, 2021 | -0.2792 |
| June 30, 2021 | -0.0926 |
| March 31, 2021 | -0.2912 |
| December 31, 2020 | -0.2215 |
| September 30, 2020 | -4.757 |
| June 30, 2020 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -1.176 |
| NovelStem International Corp. | -0.0017 |
| Brainstorm Cell Therapeutics, Inc. | -0.3494 |
| Summit Therapeutics, Inc. | -0.2772 |
| Kezar Life Sciences, Inc. | -0.7838 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -55.34M |
| Total Expenses (Quarterly) | 55.34M |
| Enterprise Value | 2.706B |
| Earnings Yield | -3.83% |
| Normalized Earnings Yield | -3.834 |